123 related articles for article (PubMed ID: 31746087)
81. [Fever with chemotherapy induced neutropenia].
Conen K
Ther Umsch; 2014 Jan; 71(1):17-22. PubMed ID: 24394205
[TBL] [Abstract][Full Text] [Related]
82. The HemoCue WBC DIFF system could be used for leucocyte and neutrophil counts but not for full differential counts.
Karawajczyk M; Haile S; Grabski M; Larsson A
Acta Paediatr; 2017 Jun; 106(6):974-978. PubMed ID: 28218961
[TBL] [Abstract][Full Text] [Related]
83. Impact of genetic polymorphisms determining leukocyte/neutrophil count on chemotherapy toxicity.
Glisovic SJ; Pastore YD; Gagne V; Plesa M; Laverdière C; Leclerc JM; Sinnett D; Krajinovic M
Pharmacogenomics J; 2018 Apr; 18(2):270-274. PubMed ID: 28534526
[TBL] [Abstract][Full Text] [Related]
84. Fluctuations in routine blood count might signal severe immune-related adverse events in melanoma patients treated with nivolumab.
Fujisawa Y; Yoshino K; Otsuka A; Funakoshi T; Fujimura T; Yamamoto Y; Hata H; Gosho M; Tanaka R; Yamaguchi K; Nonomura Y; Hirai I; Furudate S; Okuhira H; Imafuku K; Aoki M; Matsushita S
J Dermatol Sci; 2017 Nov; 88(2):225-231. PubMed ID: 28736218
[TBL] [Abstract][Full Text] [Related]
85. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial.
Keitel K; Kagoro F; Samaka J; Masimba J; Said Z; Temba H; Mlaganile T; Sangu W; Rambaud-Althaus C; Gervaix A; Genton B; D'Acremont V
PLoS Med; 2017 Oct; 14(10):e1002411. PubMed ID: 29059253
[TBL] [Abstract][Full Text] [Related]
86. FACTORS ASSOCIATED WITH TREATMENT OUTCOME OF PEDIATRIC CANCERPATIENTS ADMITTED WITH FEBRILE NEUTROPENIA IN TIKURANBESSA SPECIALIZED TEACHING HOSPITAL, ADDIS ABABA, ETHIOPIA.
Assefa S; Alemayehu T; Abebe W
Ethiop Med J; 2017 Jan; 55(1):43-7. PubMed ID: 29148638
[TBL] [Abstract][Full Text] [Related]
87. Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.
Chamilos G; Bamias A; Efstathiou E; Zorzou PM; Kastritis E; Kostis E; Papadimitriou C; Dimopoulos MA
Cancer; 2005 Jun; 103(12):2629-35. PubMed ID: 15856427
[TBL] [Abstract][Full Text] [Related]
88. Self-administered antibiotic therapy for chemotherapy-induced, low-risk febrile neutropenia in patients with nonhematologic neoplasms.
Malik IA; Khan WA; Aziz Z; Karim M
Clin Infect Dis; 1994 Sep; 19(3):522-7. PubMed ID: 7811873
[TBL] [Abstract][Full Text] [Related]
89. Understanding idiosyncratic drug-induced neutropenia.
Kessenich CR
Nurse Pract; 2010 May; 35(5):18-9. PubMed ID: 20395760
[No Abstract] [Full Text] [Related]
90. Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve.
Portugal RD; Garnica M; Nucci M
J Clin Oncol; 2009 Aug; 27(23):3849-54. PubMed ID: 19597026
[TBL] [Abstract][Full Text] [Related]
91. The white cell count in typhoid fever.
Abdool Gaffar MS; Seedat YK; Coovadia YM; Khan Q
Trop Geogr Med; 1992 Jan; 44(1-2):23-7. PubMed ID: 1496717
[TBL] [Abstract][Full Text] [Related]
92. Blood neutrophil increment after a single injection of rhG-CSF or rhGM-CSF correlates with marrow cellularity and may predict the grade of neutropenia after chemotherapy.
Hansen PB; Johnsen HE; Ralfkiaer E; Hansen NE
Br J Haematol; 1993 Aug; 84(4):581-5. PubMed ID: 7692936
[TBL] [Abstract][Full Text] [Related]
93. White blood cell count in healthy Sierra Leoneans.
Sahr F; Hazra PK; Grillo TA
West Afr J Med; 1995; 14(2):105-7. PubMed ID: 7495710
[TBL] [Abstract][Full Text] [Related]
94. Fully integrated point-of-care blood cell count using multi-frame morphology analysis.
Zhang W; Li Y; Chen B; Zhang Y; Du Z; Xiang F; Hu Y; Meng X; Shang C; Liang S; Yang X; Guan W
Biosens Bioelectron; 2023 Mar; 223():115012. PubMed ID: 36542936
[TBL] [Abstract][Full Text] [Related]
95. Label-free deep-UV microscopy detection and grading of neutropenia using a passive microfluidic device.
Ojaghi A; Kendall Williams E; Kaza N; Gorti V; Choi H; Torey J; Wiley T; Turner B; Jackson S; Park S; Lam WA; Robles FE
Opt Lett; 2022 Nov; 47(22):6005-6008. PubMed ID: 37219158
[TBL] [Abstract][Full Text] [Related]
96. [Benign ethnic neutropenia; an unrecognised cause of leukopenia in negroid patients].
van Rooijen CR; Slieker WA; Simsek S
Ned Tijdschr Geneeskd; 2012; 156(23):A4708. PubMed ID: 22727232
[TBL] [Abstract][Full Text] [Related]
97. Evaluation of the HemoCue WBC DIFF in leukopenic patient samples.
Kur DK; Agersnap N; Holländer NH; Pedersen OBV; Friis-Hansen L
Int J Lab Hematol; 2020 Jun; 42(3):256-262. PubMed ID: 32039560
[TBL] [Abstract][Full Text] [Related]
98. Preparing of Point-of-Care Reagents for Risk Assessment in the Elderly at Home by a Home-Visit Nurse and Verification of Their Analytical Accuracy.
Takenaka S; Moro H; Shimizu U; Koizumi T; Nagano K; Edanami N; Ohkura N; Domon H; Terao Y; Noiri Y
Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510151
[TBL] [Abstract][Full Text] [Related]
99. Point-of-care testing technologies for the home in chronic kidney disease: a narrative review.
Bodington R; Kassianides X; Bhandari S
Clin Kidney J; 2021 Nov; 14(11):2316-2331. PubMed ID: 34751234
[TBL] [Abstract][Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
